NCT07631845 Music Breathing in Enhancing Resilience Among Elders at Risk of Mental Health Problems
| NCT ID | NCT07631845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Resilience |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-06-08 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-06-08 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot randomised controlled trial is to examine the effects of a mindfulness-based music breathing intervention in enhancing resilience (primary outcome), and in reducing anxiety, depressive symptoms, loneliness, and improving health-related quality of life (secondary outcomes) among community-dwelling older adults at risk of mental health problems. It is hypothesised that compared with the control group, participants in the intervention group will report enhanced resilience, reduced anxiety, depressive symptoms, and loneliness, and improved health-related quality of life immediately post-intervention.
Eligibility Criteria
Inclusion Criteria: * Aged 65 years or above * Able to read Chinese and communicate in Cantonese/Mandarin. * Has mild to moderate anxiety and/or depressive symptoms, based on the - Hospital Anxiety and Depression Scale (HADS) (i.e., a score of 8 or higher on either the anxiety or depression subscale) Exclusion Criteria: * Partcipants will be excluded if they have cognitive impairment, hearing loss, severe depression, known mental illness, or chronic illness.
Contact & Investigator
Ankie Tan Cheung, PhD, MPhil, BN
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT07631845 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Resilience. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07631845 currently recruiting?
Yes, NCT07631845 is actively recruiting participants. Contact the research team at ankiecheung@cuhk.edu.hk for enrollment information.
Where is the NCT07631845 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07631845 clinical trial?
NCT07631845 is sponsored by Chinese University of Hong Kong. The principal investigator is Ankie Tan Cheung, PhD, MPhil, BN at Chinese University of Hong Kong. The trial plans to enroll 40 participants.